SB2330 - 104th General Assembly
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| 1 | AN ACT concerning criminal law. | |||||||||||||||||||
| 2 | Be it enacted by the People of the State of Illinois, | |||||||||||||||||||
| 3 | represented in the General Assembly: | |||||||||||||||||||
| 4 | Section 5. The Unified Code of Corrections is amended by | |||||||||||||||||||
| 5 | adding Section 3-6-9 as follows: | |||||||||||||||||||
| 6 | (730 ILCS 5/3-6-9 new) | |||||||||||||||||||
| 7 | Sec. 3-6-9. Treatment for committed persons with substance | |||||||||||||||||||
| 8 | use disorders. | |||||||||||||||||||
| 9 | (a) The General Assembly finds the followings: | |||||||||||||||||||
| 10 | (1) The Department of Corrections does not currently | |||||||||||||||||||
| 11 | have extensive medication-assisted treatment programs | |||||||||||||||||||
| 12 | readily available to meet the needs of all committed | |||||||||||||||||||
| 13 | persons with opioid use disorder, despite estimates that | |||||||||||||||||||
| 14 | more than half of the committed population meets the | |||||||||||||||||||
| 15 | criteria for having a substance use disorder. | |||||||||||||||||||
| 16 | (2) Providing timely access to medication-assisted | |||||||||||||||||||
| 17 | treatment in correctional settings reduces recidivism, | |||||||||||||||||||
| 18 | overdose risk following release, and improves treatment | |||||||||||||||||||
| 19 | retention. Withholding evidence-based opioid use disorder | |||||||||||||||||||
| 20 | treatment increases risk for death during detainment and | |||||||||||||||||||
| 21 | upon release. | |||||||||||||||||||
| 22 | (3) According to the Department of Human Services, up | |||||||||||||||||||
| 23 | to 75% of parolees who leave prison without treatment for | |||||||||||||||||||
| |||||||
| |||||||
| 1 | an identified substance use disorder resume substance use | ||||||
| 2 | within 3 months of release. | ||||||
| 3 | (4) Studies demonstrate that in the first 2 weeks | ||||||
| 4 | after release, the risk of opioid overdose is 40 times | ||||||
| 5 | higher for those who were incarcerated compared to the | ||||||
| 6 | general population. | ||||||
| 7 | (5) It is the stated position of the U.S. Substance | ||||||
| 8 | Abuse and Mental Health Services Administration that no | ||||||
| 9 | justification exists for denying access to medications for | ||||||
| 10 | opioid use disorder because psychosocial services are | ||||||
| 11 | unavailable or individuals are unwilling to avail | ||||||
| 12 | themselves of those services. | ||||||
| 13 | (6) The U.S. Department of Justice has determined that | ||||||
| 14 | individuals with opioid use disorder are protected under | ||||||
| 15 | the Americans with Disabilities Act of 1990. | ||||||
| 16 | (7) In community-based settings, such as opioid | ||||||
| 17 | treatment programs and primary care facilities, | ||||||
| 18 | medication-assisted treatment has been proven to reduce | ||||||
| 19 | overdose deaths and illicit opioid use. Individuals with | ||||||
| 20 | opioid use disorder living in correctional settings are | ||||||
| 21 | entitled to the same level of care as those in | ||||||
| 22 | community-based settings. | ||||||
| 23 | (b) In alignment with the State of Illinois Overdose | ||||||
| 24 | Action Plan, the purpose of this Section is to facilitate | ||||||
| 25 | timely access to medication-assisted treatment options and | ||||||
| 26 | therapies to all individuals under the care of the Department | ||||||
| |||||||
| |||||||
| 1 | of Corrections who are diagnosed with opioid use disorder. | ||||||
| 2 | (c) In this Section: | ||||||
| 3 | "Authorized health care professional" means a physician | ||||||
| 4 | licensed to practice medicine in all its branches, a licensed | ||||||
| 5 | physician assistant with prescriptive authority, a licensed | ||||||
| 6 | advanced practice registered nurse with prescriptive | ||||||
| 7 | authority, an advanced practice registered nurse or physician | ||||||
| 8 | assistant who practices in a hospital, hospital affiliate, or | ||||||
| 9 | ambulatory surgical treatment center and possesses appropriate | ||||||
| 10 | clinical privileges in accordance with the Nurse Practice Act, | ||||||
| 11 | or a pharmacist licensed to practice pharmacy under the | ||||||
| 12 | Pharmacy Practice Act. | ||||||
| 13 | "Department" means the Department of Corrections. | ||||||
| 14 | "Medication-assisted treatment" means the use of U.S. Food | ||||||
| 15 | and Drug Administration-approved medications, in combination | ||||||
| 16 | with counseling and behavioral therapies, to provide a whole | ||||||
| 17 | patient approach to the treatment of substance use disorders. | ||||||
| 18 | (d) The Department shall be required to ensure all persons | ||||||
| 19 | under its care are assessed for substance use disorder, as | ||||||
| 20 | defined in the Substance Use Disorder Act. This process | ||||||
| 21 | includes screening and assessment for opioid use disorders. | ||||||
| 22 | For a committed person diagnosed with opioid use disorder, the | ||||||
| 23 | Department shall offer, or facilitate access to, all | ||||||
| 24 | medication-assisted treatment options deemed appropriate by an | ||||||
| 25 | authorized health care professional. The Department shall not | ||||||
| 26 | impose limitations on the types of medication assisted | ||||||
| |||||||
| |||||||
| 1 | treatment that may be recommended by an authorized health care | ||||||
| 2 | professional as part of a treatment plan. | ||||||
| 3 | (e) An individual receiving medication-assisted treatment | ||||||
| 4 | prior to being committed to a Department of Corrections | ||||||
| 5 | facility shall be entitled to, upon request, continue such | ||||||
| 6 | treatment in the medication assisted treatment program for any | ||||||
| 7 | period of time deemed medically necessary by an authorized | ||||||
| 8 | health care professional. No person shall be denied | ||||||
| 9 | participation in medication-assisted treatment program on the | ||||||
| 10 | basis of a positive drug screening upon entering the | ||||||
| 11 | Department's custody; nor shall any person receive a | ||||||
| 12 | disciplinary infraction for such positive drug screen. No | ||||||
| 13 | person shall be denied participation in medication-assisted | ||||||
| 14 | treatment based on prior success or failure of any | ||||||
| 15 | medication-assisted treatment program. | ||||||
| 16 | (f) For each Parole District, the Department shall develop | ||||||
| 17 | a plan to facilitate access to medication-assisted treatment | ||||||
| 18 | for persons diagnosed with opioid use disorder in the | ||||||
| 19 | community following release. | ||||||
| 20 | (g) The Department may adopt rules for the implementation | ||||||
| 21 | of this Section. | ||||||
| 22 | Section 99. Effective date. This Act takes effect January | ||||||
| 23 | 1, 2026. | ||||||
